InflaRx to Showcase Innovations at Upcoming Investor Events
InflaRx to Showcase Innovations at Upcoming Investor Events
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company focused on pioneering anti-inflammatory therapeutics by targeting the complement system, has announced its participation in two key investor conferences in September 2024. This participation highlights the company's commitment to communicate its advancements and strategic direction to investors.
Details of the Upcoming Conferences
InflaRx will participate in the H.C. Wainwright 26th Annual Global Investment Conference occurring from September 9 to 11. During this event, InflaRx will provide an on-demand virtual presentation starting September 9, allowing investors to engage with the company's innovation remotely. Moreover, the company will also attend one-on-one investor meetings in New York City on September 10. This format not only facilitates direct engagement with investors but also enhances the potential for partnership discussions.
Fireside Chat at the Cantor Conference
Following the H.C. Wainwright conference, InflaRx will also be present at the 2024 Cantor Global Healthcare Conference, scheduled for September 17 to 19. At this conference, a significant highlight will be InflaRx's fireside chat on September 18 at 9:45 AM ET, where key company representatives will discuss its strategic innovations and the potential impacts on the healthcare landscape. Additionally, the company will hold one-on-one meetings with investors on the same day, reinforcing its openness to dialogue and collaboration.
Innovative Therapeutics by InflaRx
InflaRx is known for its advanced research and development of anti-inflammatory therapeutics. The company utilizes its proprietary anti-C5a and anti-C5aR technologies to discover, develop, and commercialize potent and specific inhibitors targeting the complement activation factor C5a and its receptor C5aR. These innovations are particularly relevant for addressing a wide variety of inflammatory diseases, positioning InflaRx at the forefront of therapeutic advancements in this area.
Lead Product Candidate
The lead product candidate, vilobelimab, is a first-in-class monoclonal antibody that demonstrates promising clinical activity. This intravenously delivered treatment binds selectively to free C5a, showing beneficial disease-modifying effects and tolerability across multiple clinical studies involving various indications. Furthermore, InflaRx is developing INF904, an orally administered small molecule designed to inhibit the C5a receptor, representing another important step in its innovative pipeline.
Company Background and Contact Information
Founded in 2007, InflaRx has established a strong presence in both Germany and the USA, positioning itself strategically for research and collaboration opportunities. With offices located in Jena and Munich, Germany, and Ann Arbor, MI, USA, the company has expanded its influence in the biopharmaceutical landscape.
For any inquiries related to investor relations, interested parties can reach out to:
InflaRx N.V.
Jan Medina, CFA
Vice President, Head of Investor Relations
Email: IR@inflarx.de
MC Services AG
Katja Arnold, Laurie Doyle, Dr. Regina Lutz
Email: inflarx@mc-services.eu
Europe: +49 89-210 2280
U.S.: +1-339-832-0752
Frequently Asked Questions
What types of conferences is InflaRx participating in?
InflaRx will participate in the H.C. Wainwright 26th Annual Global Investment Conference and the 2024 Cantor Global Healthcare Conference.
When is InflaRx's fireside chat scheduled?
The fireside chat at the Cantor Global Healthcare Conference is scheduled for September 18 at 9:45 AM ET.
What is InflaRx's lead product candidate?
InflaRx's lead product candidate is vilobelimab, an anti-C5a monoclonal antibody that shows promise in treating inflammatory diseases.
Where is InflaRx located?
InflaRx has offices in Jena and Munich, Germany, as well as Ann Arbor, MI, USA.
How can investors contact InflaRx?
Investors can contact InflaRx's investor relations through Jan Medina at IR@inflarx.de or through the contact details provided for MC Services AG.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Calumet Secures Strategic Partnership with Stonebriar Finance
- VF Corp Finalizes Major Sale, Impacts Future Strategies
- Tupperware Brands Shifts Trading to OTC Markets amid Challenges
- Devon Energy's Major Resale of Common Stock Following Acquisition
- Hyperscale Data's Strategic $13.2M Property Sale Explained
- Changes in Leadership at ON Semiconductor Amid Growth Surge
- Virpax Pharmaceuticals Welcomes Katharyn Field as VP
- Biden Urges Immediate Aid for Hurricane Helene Victims Now
- EVgo and Trump Media: Latest Post-Market Stock Reactions
- Constellation Brands Showcases Strong Beer Growth Amid Challenges
Recent Articles
- COSCIENS Biopharma's DETECT-Trial Reveals Surprising Results
- ProKidney to Attend Major Healthcare Conference
- Fancamp Partners with Lode Gold to Enhance Mineral Assets
- Avicanna Secures Patent for Innovative Topical Cannabinoid Technology
- Cartier Resources Reports High-Grade Gold Intersections
- Abcourt Mines Reports High-Grade Gold Intersections
- Bread Financial™ to Engage at Barclays Financial Services Conference
- CERIS Innovations in Fraud Prevention Solutions
- Archrock Completes HSR Act Waiting Period for Acquisition
- SEALSQ Corp Innovations in Quantum-Resistant Digital Wallets
- Investing Insights into Berkshire Hathaway's Performance
- Investing in Current Stock Market Giants
- Ozempic's Impact on Novo Nordisk: Recent Findings
- Mural Oncology to Join Major Investor Conferences
- European Wax Center to Speak at Piper Sandler Conference
- EyePoint Pharmaceuticals Prepares for Investor Conferences
- Super Hi Reports Strong Q2 2024 Financial Results
- Invivyd's PEMGARDA™ Shows 84% Risk Reduction in COVID-19
- Supremex Launches First Environmental, Social and Governance Report
- Fox Factory's Commitment to Sustainability in 2023
- Clearside Biomedical Completes Final Participant Visit in ODYSSEY Trial
- Advancements in the Cosmetic Peptide Synthesis Market
- Vacuum Evaporation Boat Market Expected Growth to $4.1 Billion
- Skydance Media to Acquire Paramount Global Amid Bidding War
- Solar Coca-Cola Boosts Delivery Efficiency with Descartes
- Palo Alto Networks: AI and Cybersecurity Leadership
- Alliance Trust PLC Reports Latest Net Asset Value Insights
- Scotiabank Reports Drop in Q3 Profit Amid Credit Loss Provisions
- Iovance Biotherapeutics: A Path to Growth with Amtagvi
- Market Update: Investors Eye Nvidia's Earnings
- Aircraft Ground Support Equipment Market Growth Insights
- 3D Printing Glasses Market Growth Forecast
- Underground Mining Equipment Market Growth Forecast
- Laser Gas Analyzer Market Set to Reach $5.39 Billion by 2034
- Cheer Holding Secures Patent for AI Data Management System
- Parsons Announces Lead Engineering Role on Toll Lane Project
- Kronos Advanced Technologies to Acquire Suarez Corporation
- Disclosure of Interests by Rathbones Group Plc
- Key Disclosure by Rathbones Group Plc in Keywords Studios Plc
- Discover Wall Street's Top Dividend Stocks
- Top Stocks to Consider Ahead of Fed Rate Cuts
- Three AI Stocks Competing with Nvidia's Growth
- Epoxy Curing Agents Market Forecast to Reach USD 10.1 Billion
- Bitumen Market Projections: USD 116 Billion by 2034
- Toughened Glass Market Growth Forecast to Reach USD 94.6 Billion
- Calibre Enhances Gold Exploration Results at Pan Mine
- Jiayin Group Inc. Reports Strong Q2 2024 Financial Results
- Matrix Service Company Announces Fourth Quarter Financial Call
- Record High Household Debt in Canada: Insights and Implications
- LanzaTech's Upcoming Investor Events Engagement